[1]
M. Karimi and V. De Sanctis, “Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the ‘high clinical risk’ category?”,
Acta Biomed
, vol. 91, no. 2, pp. 50–56, May 2020, doi:
10.23750/abm.v91i2.9592
.